The potential of MCM8 as a biomarker in esophageal carcinoma: a comprehensive analysis integrating m6a methylation and angiogenesis
MCM8 is a promising biomarker in ESCA and it is associated with m6a methylation and angiogenesis, showing potential as a therapeutic target. The ceRNA network provided insight into the pathogenesis of ESCA.
Authors
- Liping Dai
- Zhi‐Jun Pei (ORCID: https://orcid.org/0000-0001-6125-0626)
- Ao Li (ORCID: https://orcid.org/0000-0001-7861-6313)
- Yu Zhang (ORCID: https://orcid.org/0000-0003-1375-1594)
- Jie Liu (ORCID: https://orcid.org/0000-0002-1856-8564)
- Xu‐Sheng Liu (ORCID: https://orcid.org/0000-0002-3663-1096)
- Yong Xu (ORCID: https://orcid.org/0000-0001-7884-8376)
- Jin Xie
Institutions
- Hubei University of Medicine (CN)
- Wuhan University (CN)
- Soochow University (CN)
- Taihe Hospital (CN)
- Second Affiliated Hospital of Soochow University (CN)
- Renmin Hospital of Wuhan University (CN)
Publication Details
- Journal
- European journal of medical research
- Published
- 2025-05-09
- DOI
- https://doi.org/10.1186/s40001-025-02541-3
- Citations
- 2
- Primary Topic
- RNA modifications and cancer
- Type
- article
- Field-Weighted Citation Impact
- 1.61
Funders
- National Natural Science Foundation of China
- Natural Science Foundation of Hubei Province
- Hubei University of Medicine
- Hubei University